Pharmaceutical product and active pharmaceutical ingredients (APIs) can be contaminated by other pharmaceutical products or APIs, by cleaning agents, by microorganisms or by other materials e.g. air borne particle, dust, lubricants, raw materials, intermediates. Mainly cleaning is performed to remove product and non-product contaminating material. Ineffective cleaning can lead to adulterated pr...

pharmaceutical industry is currently undergoing a transient phase with new orientation. loss of financial resources, presence of new therapeutic agents and increasing cost of research and development have called for a full.scale restructuring within the pharmaceutical industry to retain even the most basic competitiveness. the development of new technologies has been as one way out of the dilem...

The purpose of present article is to discuss the concept of pharmaceutical Quality by Design (QbD) and describe how it can be help to ensure pharmaceutical quality. Quality by design is an essential part of the modern approach to pharmaceutical quality. The elements of quality by design are examined and a consistent nomenclature for quality by design, critical quality attribute, critical proces...

as global competition intensifies, research and development (r & d) organizations need to enhance their strategic management in order to become goal-directed communities for innovation and allocate their resources consistent with their overall r & d strategy. the world pharmaceutical market has undergone fast, unprecedented, tremendous and complex changes in the last several years. the pharmace...

BACKGROUND Online drug information compendia (ODIC) are valuable tools that health care professionals (HCPs) and consumers use to educate themselves on pharmaceutical products. Research suggests that these resources, although informative and easily accessible, may contain misinformation, posing risk for product misuse and patient harm. OBJECTIVE Evaluate drug summaries within ODIC for accurac...

Our study devotes special attention to the fact that R&D cooperations in the pharmaceutical industry are formed at different stages throughout the drug development process. We study how the timing to engage in R&D cooperations in the pharmaceutical industry impacts firms performance in technology and product markets. Using a comprehensive dataset on the pharmaceutical industry, and estimating a...